Interleukin Genetics' Q3 Revenues Tumble 45 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – Genetic testing company Interleukin Genetics reported after the close of the market on Wednesday a 45 percent drop year over year in its third-quarter revenues.

Total revenues during the quarter fell to $420,011 from $765,416 as genetic testing service revenues fell to $383,064 from $731,194 a year ago, a 48 percent decrease. Other revenues inched up 8 percent to $36,947 from $34,222.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.